Lupvindol Biosciences Opens Second INAD File with FDA for Investigational Combination Therapy Targeting Equine Osteoarthritis
Lupvindol Biosciences Ltd., a pioneer in steroid-sparing therapies for inflammation and pain, today announced that the U.S. Food and Drug […]
